Test Price
2,800 AED✅ Home Collection Available
LIFR Gene Stuve‑Wiedemann Syndrome Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
99.9% Diagnostic Sensitivity
ISO 9001:2015 accredited Next‑Generation Sequencing (NGS) – precise detection of LIFR gene variants responsible for Stuve‑Wiedemann syndrome.
VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection
Hospital‑grade phlebotomy and ISO‑certified cold‑chain transport available daily from 8 AM to 11 PM. Blood, extracted DNA, or FTA card accepted.
Post‑Test Clinical Guidance
Telephonic result interpretation with a DHA‑licensed expert included.
Insurance Direct Billing
Verify coverage instantly via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This test uses Next‑Generation Sequencing (NGS) to identify disease‑causing mutations in the LIFR gene, confirming Stuve‑Wiedemann syndrome (SWWS) – a rare autosomal recessive osteochondrodysplasia characterized by bone dysplasia, dysmorphic features, and early respiratory distress. Early molecular diagnosis guides multidisciplinary management and family counselling.
| Feature | Our LIFR NGS Test | Closest Alternative |
|---|---|---|
| Precision | Full LIFR gene coverage (coding exons ±20 bp) with high depth | Sanger sequencing – limited to single exon or hotspot |
| Methodology | NGS (Illumina platform, LC‑MS/MS‑free) | Conventional PCR plus Sanger |
| Turnaround Time | 3–4 weeks | 6–8 weeks |
Physician Insight & Safety Protocols
“This LIFR gene NGS analysis provides definitive molecular confirmation for Stuve‑Wiedemann syndrome, a condition that demands correlation with dysmorphology assessment, skeletal radiology, and detailed family pedigree. Pre‑test genetic counselling is mandatory for every patient to ensure fully informed consent. Never adjust or discontinue prescribed medications without explicit guidance from your treating physician.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
Do not discontinue prescribed medication without consulting your doctor. Abrupt cessation may lead to serious adverse events.
Exclusion Criteria & Emergency Red Flags
- Patient on anticoagulant therapy unless cleared by the treating physician.
- Age below 18 without formal guardian consent per UAE Federal Law.
- Emergency symptoms: sudden respiratory distress, severe bone pain, inability to feed in neonates – seek immediate hospital care.
Patient FAQ & Clinical Guidance
1. What is the LIFR gene Stuve‑Wiedemann syndrome NGS test?
This test sequences the entire LIFR gene using Next‑Generation Sequencing to identify pathogenic variants responsible for Stuve‑Wiedemann syndrome, a congenital bone dysplasia. It requires a blood, extracted DNA, or FTA card sample and provides definitive molecular diagnosis in 3–4 weeks. Results guide multidisciplinary care including neonatology, orthopedics, and clinical genetics.
2. How should I prepare for the LIFR gene test?
A clinical history and pedigree chart documenting affected family members are essential; a pre‑test genetic counselling session is mandatory to ensure informed consent. No fasting is required, and VIP mobile phlebotomy home collection can be arranged from 8 AM to 11 PM daily via temperature‑controlled cold‑chain logistics.
3. Which specialists should interpret the result?
The analysis should be reviewed by a multi‑disciplinary team including a pediatrician, neonatologist, and a clinical geneticist to correlate molecular findings with the patient’s clinical picture. Our post‑test guidance connects you with DHA‑licensed experts for comprehensive result explanation.
4. Is home collection available for this genetic test?
Yes. Since the specimen is peripheral whole blood or extracted DNA, our VIP Mobile Phlebotomy service operates daily from 8 AM to 11 PM with ISO‑certified cold‑chain transport. A trained phlebotomist visits your home, collects the sample, and ensures safe delivery to our CLIA‑compliant laboratory.
UAE Regulatory & Data Privacy Adherence
Your Data Is Protected Under UAE Law
All genetic data generated by this test is processed and stored in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent protocols follow Federal Decree-Law No. 4 of 2016 on Medical Liability. DNA Labs UAE maintains rigorous data encryption, access control, and audit logging to safeguard your health information.
Clinical & Logistical Metadata
| Test Name | LIFR Gene Stuve‑Wiedemann Syndrome NGS Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral whole blood, extracted DNA, or FTA card |
| Methodology Used | Next‑Generation Sequencing (NGS) – Illumina platform, full gene coverage |
| ICD-10-CM Code | Q87.8 |
| LOINC Code | 82373-9 |
| DHA Facility License & Laboratory Address | License 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians